Carmell (CTCX) Competitors $0.16 +0.00 (+2.63%) As of 04/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTCX vs. QTI, XAIR, LFWD, NRXS, PETV, VVOS, PAVM, CODX, ALUR, and PSTVShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include QT Imaging (QTI), Beyond Air (XAIR), ReWalk Robotics (LFWD), NeurAxis (NRXS), PetVivo (PETV), Vivos Therapeutics (VVOS), PAVmed (PAVM), Co-Diagnostics (CODX), Allurion Technologies (ALUR), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Carmell vs. QT Imaging Beyond Air ReWalk Robotics NeurAxis PetVivo Vivos Therapeutics PAVmed Co-Diagnostics Allurion Technologies Plus Therapeutics QT Imaging (NASDAQ:QTI) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Does the MarketBeat Community prefer QTI or CTCX? QT Imaging and Carmell both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformQT ImagingN/AN/ACarmellN/AN/A Do insiders & institutionals have more ownership in QTI or CTCX? 24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by insiders. Comparatively, 29.0% of Carmell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to QTI or CTCX? In the previous week, QT Imaging had 1 more articles in the media than Carmell. MarketBeat recorded 1 mentions for QT Imaging and 0 mentions for Carmell. QT Imaging's average media sentiment score of 1.88 beat Carmell's score of 0.52 indicating that QT Imaging is being referred to more favorably in the media. Company Overall Sentiment QT Imaging Very Positive Carmell Positive Which has better earnings & valuation, QTI or CTCX? QT Imaging has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQT Imaging$4.00M4.96-$4.03MN/AN/ACarmell$32.84K104.53-$15.44MN/AN/A Is QTI or CTCX more profitable? QT Imaging's return on equity of 0.00% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets QT ImagingN/A N/A -65.94% Carmell N/A -217.50%-50.22% Which has more risk & volatility, QTI or CTCX? QT Imaging has a beta of -0.2, meaning that its share price is 120% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. SummaryQT Imaging beats Carmell on 6 of the 10 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.43M$4.35B$5.46B$7.81BDividend YieldN/A46.48%5.43%4.30%P/E RatioN/A30.7422.2518.42Price / Sales104.5353.01391.10101.46Price / CashN/A51.0838.1834.62Price / Book0.156.146.674.19Net Income-$15.44M$68.15M$3.21B$247.97M7 Day Performance5.12%4.66%6.20%6.52%1 Month Performance1.67%-6.91%-2.85%-2.17%1 Year Performance-92.14%27.39%16.41%4.70% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$0.16+2.6%N/A-92.3%$3.43M$32,839.000.0014QTIQT ImagingN/A$0.61+1.7%N/A-6.2%$16.55M$4.00M0.00N/AXAIRBeyond Air4.3804 of 5 stars$0.23flat$3.67+1,467.0%-81.5%$16.10M$3.02M-0.2270News CoverageLFWDReWalk Robotics2.519 of 5 stars$1.45+0.7%$9.00+520.7%-68.2%$15.41M$25.66M-0.5860News CoveragePositive NewsGap UpNRXSNeurAxisN/A$1.85+6.9%N/A-18.7%$13.34M$2.69M-1.0019News CoveragePETVPetVivoN/A$0.55+9.9%N/A-31.9%$13.07M$1.05M-1.2220High Trading VolumeVVOSVivos Therapeutics2.803 of 5 stars$2.22-1.4%$6.10+174.9%+6.9%$12.93M$15.03M-0.39160Short Interest ↓Positive NewsGap UpPAVMPAVmed4.4162 of 5 stars$0.72-0.3%$19.00+2,546.2%-56.3%$12.27M$3.00M-0.1790Short Interest ↓Positive NewsGap UpCODXCo-Diagnostics4.1678 of 5 stars$0.36-0.4%$1.00+177.0%-69.3%$12.12M$3.92M-0.26100Positive NewsGap DownALURAllurion Technologies2.8193 of 5 stars$2.49-2.9%$22.83+818.8%-94.9%$11.92M$32.11M-0.21501Short Interest ↓Gap DownPSTVPlus Therapeutics1.7404 of 5 stars$0.66+3.0%$11.17+1,594.5%-52.7%$11.58M$4.91M-0.2720Gap DownHigh Trading Volume Related Companies and Tools Related Companies QTI Alternatives XAIR Alternatives LFWD Alternatives NRXS Alternatives PETV Alternatives VVOS Alternatives PAVM Alternatives CODX Alternatives ALUR Alternatives PSTV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTCX Stock Free CTCX Stock Alerts